162 related articles for article (PubMed ID: 15210692)
1. Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A.
Wu AY; Tang XB; Martinez SE; Ikeda K; Beavo JA
J Biol Chem; 2004 Sep; 279(36):37928-38. PubMed ID: 15210692
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase.
Huang D; Hinds TR; Martinez SE; Doneanu C; Beavo JA
J Biol Chem; 2004 Nov; 279(46):48143-51. PubMed ID: 15331594
[TBL] [Abstract][Full Text] [Related]
3. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.
Martinez SE; Wu AY; Glavas NA; Tang XB; Turley S; Hol WG; Beavo JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13260-5. PubMed ID: 12271124
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
[TBL] [Abstract][Full Text] [Related]
5. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
6. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
7. Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain.
Laxman S; Rascón A; Beavo JA
J Biol Chem; 2005 Feb; 280(5):3771-9. PubMed ID: 15563461
[TBL] [Abstract][Full Text] [Related]
8. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Matthiesen K; Nielsen J
Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation.
Zoraghi R; Bessay EP; Corbin JD; Francis SH
J Biol Chem; 2005 Mar; 280(12):12051-63. PubMed ID: 15677448
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change.
Heikaus CC; Stout JR; Sekharan MR; Eakin CM; Rajagopal P; Brzovic PS; Beavo JA; Klevit RE
J Biol Chem; 2008 Aug; 283(33):22749-59. PubMed ID: 18534985
[TBL] [Abstract][Full Text] [Related]
11. Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5.
Sopory S; Balaji S; Srinivasan N; Visweswariah SS
FEBS Lett; 2003 Mar; 539(1-3):161-6. PubMed ID: 12650945
[TBL] [Abstract][Full Text] [Related]
12. Binding of cGMP to GAF domains in amphibian rod photoreceptor cGMP phosphodiesterase (PDE). Identification of GAF domains in PDE alphabeta subunits and distinct domains in the PDE gamma subunit involved in stimulation of cGMP binding to GAF domains.
Yamazaki M; Li N; Bondarenko VA; Yamazaki RK; Baehr W; Yamazaki A
J Biol Chem; 2002 Oct; 277(43):40675-86. PubMed ID: 12177054
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights.
Heikaus CC; Pandit J; Klevit RE
Structure; 2009 Dec; 17(12):1551-1557. PubMed ID: 20004158
[TBL] [Abstract][Full Text] [Related]
14. Regulation of photoreceptor phosphodiesterase catalysis by its non-catalytic cGMP-binding sites.
D'Amours MR; Cote RH
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):863-9. PubMed ID: 10359674
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the tandem GAF domains from a cyanobacterial adenylyl cyclase: modes of ligand binding and dimerization.
Martinez SE; Bruder S; Schultz A; Zheng N; Schultz JE; Beavo JA; Linder JU
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3082-7. PubMed ID: 15708973
[TBL] [Abstract][Full Text] [Related]
17. A Novel Inhibition Modality for Phosphodiesterase 2A.
Nakashima K; Matsui H
SLAS Discov; 2020 Jun; 25(5):498-505. PubMed ID: 32343157
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
Soderling SH; Bayuga SJ; Beavo JA
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions.
Kapphahn MA; Shabb JB
Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
